Sickle Cell Disease Association of America, Inc. (SCDAA)
About SCDAA
Sickle Cell Research & Screening
Member Organizations
Media Canter
Annual Convention
Sickle Cell Programs & Eduation
Get Involved
Calendar of Events
Wall of Giving
Join SCDAA
SCDAA
Address
Sickle Cell Disease Association of America, Inc.
3700 Koppers Street
Suite 570
Baltimore, Maryland 21227

Office   410.528.1555
Fax   410.528.1495
Toll Free   800.421.8453


Monday - Friday:
9:00am - 5:00pm (EST)

scdaa@sicklecelldisease.org
  • Sickle Cell Conditions
News

BREAKING NEWS! SCDAA & THE SCD COMMUNITY COLLECTS 100,000 SIGNATURES!

We have reached the mandatory goal of 100,000 signatures! Now let's show the White House we mean business and collect even more! It is not too late to sign!

BREAKING NEWS! SCDAA & THE SCD COMMUNITY COLLECTS 100,000 SIGNATURES!
Sickle Cell

The SCDAA Gets Involved in #GivingTuesday

In Honor of Giving Tuesday, the Sickle Cell Disease Association would like to give YOU a gift. You could win a brand new Gibson SG Supra Guitar! Raffle tickets are just $5.00 (per ticket) and there is no limit to how many tickets you can get! All proceeds Benefit the National Sickle Cell Disease Community. Enter...

The SCDAA Gets Involved in #GivingTuesday
Sickle Cell

Sickle Cell Treatment Reauthorization Act of 2014 introduced in the House of Representatives

SCDAA along with its members, advocates and champions has secured a big win for the sickle cell community. On Wednesday, July 16, 2014 Representatives Danny K. Davis (D-IL) and Michael C. Burgess (R-TX) revealed bipartisan legislation...

Sickle Cell Treatment Reauthorization Act of 2014 introduced in the House of Representatives
Sickle Cell


Chief Medical Officer News

New report on Incidence of Sickle Cell Trait (SCT) & New Resources to Help

The sickle cell trait (SCT) toolkit is an online compilation of user friendly health education materials related to SCT. We are happy to have the opportunity to provide you or your organization with necessary tools and resources to educate yourself or the communities you serve about SCT. We hope that the...

New report on Incidence of Sickle Cell Trait (SCT) & New Resources to Help
Sickle Cell

Baxter Acquires AesRx, LLC, Including Its Investigational Sickle Cell Disease Treatment

Baxter International Inc. announced the acquisition of AesRx, LLC, including the development and commercialization of Aes-103, an investigational prophylactic treatment for sickle cell disease (SCD).

Baxter Acquires AesRx, LLC, Including Its Investigational Sickle Cell Disease Treatment
Sickle Cell

First Sickle Cell Patient Undergoes Gene Therapy

Bluebird Bio announced that the first subject with severe sickle cell disease has undergone infusion with LentiGlobin BB305 drug product in an autologous hematopoietic stem cell transplantation.

First Sickle Cell Patient Undergoes Gene Therapy
Sickle Cell


Advocacy Update


SCDAA would like to thank you for being an advocate for sickle cell disease!

Continue to check our website for updates.

Featured Event
Featured Event
Featured Event
SCDAA Corporate Sponsor